Shigeki Nakamura

Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V₂ receptor antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Hiroshi Yamashita et al. · British Journal of Pharmacology · 1992 · 347 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats

Yoshitaka Yamamura, Shigeki Nakamura, S. Itoh et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 332 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +12

Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice

Shigeki Nakamura, Kimberly M. Davis, Jeffrey N. Weiser · Journal of Clinical Investigation · 2011 · 285 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Tomihiko Chihara et al. · Science · 1991 · 272 citations

Medicine, Pharmacology, Physiology +17

Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice

Kimberly M. Davis, Shigeki Nakamura, Jeffrey N. Weiser · Journal of Clinical Investigation · 2011 · 187 citations · Full text

Life Sciences, Immunology, Microbiology +17